Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Suspended 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 40Carcinoma, Non-Small-Cell Lung 32Colorectal Neoplasms 27Ovarian Neoplasms 23Neoplasms 23Lung Neoplasms 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Pancreatic Neoplasms 17Leukemia, Myeloid, Acute 16Head and Neck Neoplasms 16Lymphoma, Non-Hodgkin 15Neoplasm Metastasis 14Fallopian Tube Neoplasms 14Glioblastoma 13Esophageal Neoplasms 12Rectal Neoplasms 11Lymphoma 11Squamous Cell Carcinoma of Head and Neck 10Central Nervous System Neoplasms 10Carcinoma, Ovarian Epithelial 10Recurrence 9Melanoma 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Leukemia 9Stomach Neoplasms 8Prostatic Neoplasms 8Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Liver Neoplasms 7

Interventions

romidepsin 12Cyclophosphamide 11Vincristine 9Rituximab 9Etoposide 9Lenalidomide 8Doxorubicin 8Brentuximab Vedotin 8fludarabine 6Prednisone 6Peripheral Blood Stem Cell Transplantation 6Melphalan 6Depsipeptides 6fludarabine phosphate 5Mycophenolic Acid 5Lactones 5Gemcitabine 5Cytarabine 5Bendamustine Hydrochloride 5Antilymphocyte Serum 5Whole-Body Irradiation 4Tacrolimus 4Sirolimus 4Methotrexate 4MLN 8237 4Carmustine 4Bortezomib 410-propargyl-10-deazaaminopterin 4thymoglobulin 3duvelisib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, T-Cell × Drug Therapy × Clear all
NCT01908777 2025-10-09

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
47 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡